{"title": "Biblio Search", "author": null, "url": "https://www.sciensano.be/nl/search/biblio/days", "hostname": "sciensano.be", "description": null, "sitename": "sciensano.be", "date": "1999-01-01", "cleaned_text": "- Bedoelde u [dans](/nl/search/biblio/dans) Zoekresultaten - 448 results [Automatic detection of airborne pollen: an overview](https://www.sciensano.be/nl/biblio/automatic-detection-airborne-pollen-overview) available with a delay of 3-9 days and usually delivered at a daily resolution. Several automatic instruments have come on to the market over the past few years, with more new devices also under development. ... [Direct impact of COVID-19 by estimating disability-adjusted life years at national level in France in 2020](https://www.sciensano.be/nl/biblio/direct-impact-covid-19-estimating-disability-adjusted-life-years-national-level-france-2020) [https://www.sciensano.be/nl/biblio/direct-impact-covid-19-estimating-disability-adjusted-life-years-national-level-france-2020](https://www.sciensano.be/nl/biblio/direct-impact-covid-19-estimating-disability-adjusted-life-years-national-level-france-2020) post-acute consequences, in 28 days (baseline) up to 140 days, following the initial infection. METHODS: National mortality, COVID-19 screening, and hospital admission data were used to calculate DALY s based ... [COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022.](https://www.sciensano.be/nl/biblio/covid-19-vaccine-effectiveness-against-symptomatic-infection-and-hospitalisation-belgium-july-2021) [https://www.sciensano.be/nl/biblio/covid-19-vaccine-effectiveness-against-symptomatic-infection-and-hospitalisation-belgium-july-2021](https://www.sciensano.be/nl/biblio/covid-19-vaccine-effectiveness-against-symptomatic-infection-and-hospitalisation-belgium-july-2021) 100-150 days after the primary vaccination course. Booster vaccination increased initial VE i to 85% (95% CI: 84-85). Against Antibody Detection in Wild Boar and Sheep: Impact of the Screening Approach on the Estimated Seroprevalence.](https://www.sciensano.be/nl/biblio/comparison-serological-methods-tick-borne-encephalitis-virus-specific-antibody-detection-wild-boar-0) [https://www.sciensano.be/nl/biblio/comparison-serological-methods-tick-borne-encephalitis-virus-specific-antibody-detection-wild-boar-0](https://www.sciensano.be/nl/biblio/comparison-serological-methods-tick-borne-encephalitis-virus-specific-antibody-detection-wild-boar-0) 18 days post-infection, the ELISA s classified only 50% and 31% of the samples as positive. Both routinely used ELISA s for TBEV antibody screening in animal sera were shown to have a low sensitivity, ... [Daily allergy burden and heart rate characteristics in adults with allergic rhinitis based on a wearable telemonitoring system](https://www.sciensano.be/nl/biblio/daily-allergy-burden-and-heart-rate-characteristics-adults-allergic-rhinitis-based-a-wearable) [https://www.sciensano.be/nl/biblio/daily-allergy-burden-and-heart-rate-characteristics-adults-allergic-rhinitis-based-a-wearable](https://www.sciensano.be/nl/biblio/daily-allergy-burden-and-heart-rate-characteristics-adults-allergic-rhinitis-based-a-wearable) participant-days of 72 participants. A one-point increase in allergy symptom score was associated with an increase in next-day resting heart rate of 0.08 (95% CI: 0.02-0.15) beats per minute. A one-point increase ... [The contribution of cacao consumption to the bioaccessible dietary cadmium exposure in the Belgian population](https://www.sciensano.be/nl/biblio/contribution-cacao-consumption-bioaccessible-dietary-cadmium-exposure-belgian-population) [https://www.sciensano.be/nl/biblio/contribution-cacao-consumption-bioaccessible-dietary-cadmium-exposure-belgian-population](https://www.sciensano.be/nl/biblio/contribution-cacao-consumption-bioaccessible-dietary-cadmium-exposure-belgian-population) the Belgian population, in combination with ICP- MS analysis of a large subset of cacao-containing products (N=349). Both the average chocolate consumption (28 g day-1) and the relative contribution of ... [Forecasting Birch Pollen Levels in Belgium: First Analysis of the 2021 Season](https://www.sciensano.be/nl/biblio/forecasting-birch-pollen-levels-belgium-first-analysis-2021-season) [https://www.sciensano.be/nl/biblio/forecasting-birch-pollen-levels-belgium-first-analysis-2021-season](https://www.sciensano.be/nl/biblio/forecasting-birch-pollen-levels-belgium-first-analysis-2021-season) Transport Models (CTM 's) are able to quantify the spatial and temporal distributions of airborne birch pollen levels a few days ahead. Recently, a new dataset on the birch pollen emission sources has been ... [Aluminium intake through the consumption of selected baby foods and risk characterization in a population of Brazilian infants aged 0 to 36 months](https://www.sciensano.be/nl/biblio/aluminium-intake-through-consumption-selected-baby-foods-and-risk-characterization-a-population) [https://www.sciensano.be/nl/biblio/aluminium-intake-through-consumption-selected-baby-foods-and-risk-characterization-a-population](https://www.sciensano.be/nl/biblio/aluminium-intake-through-consumption-selected-baby-foods-and-risk-characterization-a-population) frequency and daily food consumption (in g/day) were observed for infant formulas and meat/vegetable purees, respectively. Boys presented higher frequency consumption of infant formulas, while meat/vegetable ... [Microbiological safety of aged meat.](https://www.sciensano.be/nl/biblio/microbiological-safety-aged-meat) prevented by ensuring a meat surface temperature of-0.5 to 3.0\u00b0C, with a relative humidity (RH) of 75-85% and an airflow of 0.2-0.5 m/s for up to 35 days. The main meat include spp, spp. ... treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020.](https://www.sciensano.be/nl/biblio/effect-neuraminidase-inhibitor-oseltamivir-treatment-outcome-hospitalised-influenza-patients) [https://www.sciensano.be/nl/biblio/effect-neuraminidase-inhibitor-oseltamivir-treatment-outcome-hospitalised-influenza-patients](https://www.sciensano.be/nl/biblio/effect-neuraminidase-inhibitor-oseltamivir-treatment-outcome-hospitalised-influenza-patients) decreased risk (aOR 0.91, 95% CI: 0.90-0.93). NAI treatment initiation within 48 hours and up to 7 days reduced risk of dying (0-48 hours "}